Viracta Therapeutics
VIRX
#10423
Rank
A$1.33 M
Marketcap
$0.03358
Share price
-12.61%
Change (1 day)
-97.94%
Change (1 year)

Viracta Therapeutics (VIRX) - Cash on Hand

Cash on Hand as of September 2024 : A$35.3 Million

According to Viracta Therapeutics's latest financial reports the company has A$35.3 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Viracta Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$78.8 M-41.1%
2022-12-31A$0.13 B-6.34%
2021-12-31A$0.14 B133.24%
2020-12-31A$61.23 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.42 B 1,111.24%๐Ÿ‡บ๐Ÿ‡ธ USA